News Column

New Vaccines Findings from Pfizer Outlined

January 29, 2014



By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Immunization. According to news originating from Chesterfield, Missouri, by NewsRx correspondents, research stated, "Recombinant technology has ushered in a new era for the pharmaceutical industry. Protein therapeutics, including plasma-derived products and antibodies obtained from the serum of infected patients, have been successfully adopted and utilized to treat various indications."

Our news journalists obtained a quote from the research from Pfizer, "The development of recombinant technology and the subsequent improvement in expression, purification, and formulation technologies have enabled the generation of highly purified proteins in a scalable and cost-effective manner. The discovery and development of several recombinant proteins, such as growth factors and cytokines, will be described followed by a brief review of monoclonal antibodies and enzyme replacement therapy. Recombinant protein-based vaccine, which is the focus of the current review, is described in detail with particular emphasis on several viral and bacterial infections."

According to the news editors, the research concluded: "Challenges and new approaches in their use as a replacement for the currently available vaccines are discussed."

For more information on this research see: Recombinant therapeutic protein vaccines. Protein and Peptide Letters, 2013;20(12):1324-44. (Bentham Science Publishers - www.benthamscience.com; Protein and Peptide Letters - www.benthamscience.com/ppl/index.htm)

The news correspondents report that additional information may be obtained from S. Ohtake, Pfizer, 700 Chesterfield Parkway West, Chesterfield, MO 63017, United States (see also Immunization).

Keywords for this news article include: Antibodies, Therapy, Missouri, Vaccines, Immunology, Technology, Chesterfield, Immunization, United States, Blood Proteins, Immunoglobulins, Biological Products, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Biotech Week


Story Tools